Dermapharm Holding SE (ETR:DMP)
38.30
-0.50 (-1.29%)
Sep 10, 2026, 5:35 PM CET
Dermapharm Holding SE Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,181 | 1,165 | 1,181 | 1,135 | 1,025 | 942.91 |
Other Revenue | 0.92 | 0.92 | 0.75 | 0.42 | 0.25 | 0.49 |
| 1,182 | 1,166 | 1,182 | 1,136 | 1,025 | 943.4 | |
Revenue Growth | 0.40% | -1.32% | 4.03% | 10.80% | 8.65% | 18.74% |
Cost of Revenue | 408.93 | 412.65 | 445.6 | 446.6 | 391.85 | 349.87 |
Gross Profit | 773.39 | 753.25 | 735.91 | 689.18 | 633.18 | 593.54 |
Selling, General & Admin | 306.58 | 299.27 | 287.43 | 271.01 | 190.56 | 168.95 |
Other Operating Expenses | 133.8 | 136.55 | 144.24 | 136.24 | 102.19 | 82.99 |
Operating Expenses | 524.38 | 516.63 | 513.84 | 496.02 | 350.45 | 297.63 |
Operating Income | 249.01 | 236.62 | 222.07 | 193.16 | 282.72 | 295.91 |
Interest Expense | -45.41 | -48.67 | -58.41 | -54.97 | -12.34 | -8.84 |
Interest & Investment Income | 5.35 | 5.61 | 13.99 | 2.49 | 0.33 | 4.02 |
Earnings From Equity Investments | 3.38 | 4.34 | 1.52 | -7.16 | -13.54 | 0.32 |
Currency Exchange Gain (Loss) | -4.81 | -4.81 | 1.4 | -1.95 | 0.37 | 2.28 |
Other Non Operating Income (Expenses) | 26.57 | 1.75 | -0.96 | -16.63 | -1.12 | -0.83 |
EBT Excluding Unusual Items | 234.1 | 194.84 | 179.61 | 114.93 | 256.43 | 292.86 |
Merger & Restructuring Charges | - | - | - | - | - | -0.6 |
Impairment of Goodwill | -10.82 | -10.82 | -2.12 | - | -36.45 | -5.43 |
Gain (Loss) on Sale of Investments | - | - | -0 | -1.98 | - | 9.06 |
Gain (Loss) on Sale of Assets | 0.28 | 0.28 | 0.63 | 2.96 | 3.13 | 1.38 |
Asset Writedown | -0.92 | -0.92 | -6.21 | -15.82 | -7.03 | -4.48 |
Other Unusual Items | -30 | - | - | 5.78 | - | - |
Pretax Income | 192.77 | 183.51 | 172.01 | 106 | 216.3 | 292.98 |
Income Tax Expense | 47.23 | 52.16 | 60.27 | 45.46 | 83.68 | 84.07 |
Earnings From Continuing Operations | 145.54 | 131.35 | 111.74 | 60.53 | 132.62 | 208.9 |
Minority Interest in Earnings | 0.99 | 1.06 | 2.05 | 1.83 | 1.62 | 0.68 |
Net Income | 146.54 | 132.41 | 113.79 | 62.37 | 134.24 | 209.58 |
Net Income to Common | 146.54 | 132.41 | 113.79 | 62.37 | 134.24 | 209.58 |
Net Income Growth | 36.70% | 16.37% | 82.45% | -53.54% | -35.95% | 144.19% |
Shares Outstanding (Basic) | 53 | 54 | 54 | 54 | 54 | 54 |
Shares Outstanding (Diluted) | 53 | 54 | 54 | 54 | 54 | 54 |
Shares Change | -1.68% | - | - | - | - | - |
EPS (Basic) | 2.77 | 2.46 | 2.11 | 1.16 | 2.49 | 3.89 |
EPS (Diluted) | 2.77 | 2.46 | 2.11 | 1.16 | 2.49 | 3.89 |
EPS Growth | 39.03% | 16.37% | 82.45% | -53.54% | -35.91% | 144.65% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 215.96 | 187.03 | 163.14 | 177.88 | 249.52 | 189.17 |
Free Cash Flow Per Share | 4.08 | 3.47 | 3.03 | 3.30 | 4.63 | 3.51 |
Dividend Per Share | 0.880 | 0.880 | 0.900 | 0.880 | 1.050 | 2.170 |
Dividend Growth | -2.22% | -2.22% | 2.27% | -16.19% | -51.61% | 146.59% |
Gross Margin | 65.41% | 64.61% | 62.29% | 60.68% | 61.77% | 62.91% |
Operating Margin | 21.06% | 20.29% | 18.80% | 17.01% | 27.58% | 31.37% |
Profit Margin | 12.39% | 11.36% | 9.63% | 5.49% | 13.10% | 22.22% |
Free Cash Flow Margin | 18.27% | 16.04% | 13.81% | 15.66% | 24.34% | 20.05% |
EBITDA | 309.65 | 264.74 | 250.77 | 220.31 | 302.36 | 312.36 |
EBITDA Margin | 26.19% | 22.71% | 21.22% | 19.40% | 29.50% | 33.11% |
D&A For EBITDA | 60.64 | 28.12 | 28.7 | 27.15 | 19.64 | 16.45 |
EBIT | 249.01 | 236.62 | 222.07 | 193.16 | 282.72 | 295.91 |
EBIT Margin | 21.06% | 20.29% | 18.80% | 17.01% | 27.58% | 31.37% |
Effective Tax Rate | 24.50% | 28.42% | 35.04% | 42.89% | 38.69% | 28.70% |